Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vascular Surgery
  Free Subscription

Articles published in
Eur Heart J
    October 2026
  1. KATAOKA Y, Ray KK, Nicholls SJ, Katasako-Yabumoto A, et al
    Lipoprotein(a) and residual cardiovascular risks in Japanese patients with coronary artery disease who achieve guideline-recommended low-density lipoprotein cholesterol goals.
    Eur Heart J. 2026;47:5991-6003.
    >> Share

    July 2026
  2. PRANGE KHM, Bel-Bordes G, Depuydt MAC, Barlampas P, et al
    Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy.
    Eur Heart J. 2026;47:3821-3836.
    >> Share

    June 2026
  3. DOENST T, Prendergast B, Allen CJ, Barili F, et al
    Great debate: surgical aortic valve replacement is first choice for aortic stenosis in patients with a life expectancy beyond 5 years.
    Eur Heart J. 2026 Jun 15:ehag262. doi: 10.1093.
    >> Share

    May 2026
  4. CENKO E, Badimon L, Vadala G, Merkus D, et al
    Pathophysiology, prevention, and management of coronary microvascular obstruction.
    Eur Heart J. 2026 May 26:ehag334. doi: 10.1093.
    >> Share

  5. LEE CC, Chang FC, Hsieh MJ, Chen CY, et al
    Infected native aortic aneurysms: epidemiology, management, and outcomes based on a nationwide population-based study.
    Eur Heart J. 2026;47:2466-2477.
    >> Share

  6. JOHNSON TW, Gonzalo N, de la Torre Hernandez JM, Amabile N, et al
    Intracoronary imaging for left main percutaneous coronary intervention: a clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Bifurcation Club (EBC).
    Eur Heart J. 2026 May 15:ehag353. doi: 10.1093.
    >> Share

  7. CORTESE B, Mehilli J, Belmonte M, Wanha W, et al
    Great debate: drug-coated balloons are preferable to drug-eluting stents for coronary in-stent restenosis.
    Eur Heart J. 2026;47:2035-2043.
    >> Share

  8. ALEXANDROU M, Sandoval Y, Alfonso F, Brilakis ES, et al
    Subacute coronary artery occlusion: complexities of the grey zone.
    Eur Heart J. 2026;47:2022-2034.
    >> Share

  9. KIM JM, Yeh RW, Song Y, Secemsky EA, et al
    Drug-coated vs non-drug-coated devices for femoropopliteal artery interventions: long-term outcomes of the SAFE-PAD study.
    Eur Heart J. 2026;47:2093-2103.
    >> Share

    March 2026
  10. PARK DW, Boden WE, De Caterina R, Gallinoro E, et al
    Great debate: preventive percutaneous coronary intervention added to optimal medical treatment should be the default treatment for non-flow-limiting vulnerable plaques.
    Eur Heart J. 2026 Mar 6:ehag103. doi: 10.1093.
    >> Share

    February 2026
  11. MAZNYCZKA A, Pilgrim T, Philippon F, Rodes-Cabau J, et al
    Conduction disturbances after transcatheter aortic valve implantation.
    Eur Heart J. 2026 Feb 19:ehag093. doi: 10.1093.
    >> Share

  12. CAO JY, Egbe AC, Olsen N, Jain CC, et al
    Adults with Fontan circulation: prognostic value of exercise pulmonary vascular resistance index.
    Eur Heart J. 2026;47:854-864.
    >> Share

  13. LEE SJ, Lee SJ, Hong SJ, Cho DK, et al
    Optical coherence tomography-guided stent optimization for complex coronary lesions: the OCCUPI trial.
    Eur Heart J. 2026;47:608-621.
    >> Share

    January 2026
  14. MA WG, Chen Y, Chen SW, Zhang W, et al
    Frozen elephant trunk for acute type A aortic dissection: long-term outcomes over two decades.
    Eur Heart J. 2026 Jan 30:ehaf1117. doi: 10.1093/eurheartj/ehaf1117.
    >> Share

  15. SAVONITTO S, Alpert JS, Thiele H, Campo G, et al
    Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management.
    Eur Heart J. 2026;47:423-437.
    >> Share

  16. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
    Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION-STEMI trial.
    Eur Heart J. 2026 Jan 6:ehaf924. doi: 10.1093.
    >> Share

    December 2025
  17. RIBICHINI FL, Scarsini R, Pesarini G, Fabris T, et al
    Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial.
    Eur Heart J. 2025 Dec 19:ehaf974. doi: 10.1093.
    >> Share

    November 2025
  18. AN KR, Vervoort D, Qiu F, Tam DY, et al
    Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting.
    Eur Heart J. 2025 Nov 25:ehaf806. doi: 10.1093.
    >> Share

  19. SERRUYS PW, Oshima A, Ferraz-Costa G, Garg S, et al
    Coronary revascularization: a long-term perspective.
    Eur Heart J. 2025 Nov 22:ehaf883. doi: 10.1093.
    >> Share

    October 2025
  20. PADALINO MA, Constantine A, Bergonzoni E, Cao I, et al
    Early outcomes of children with univentricular circulation undergoing Fontan surgery: the EuroFontan registry.
    Eur Heart J. 2025 Oct 23:ehaf835. doi: 10.1093.
    >> Share

  21. LOMBARDI M, Boivin-Proulx LA, Jeronimo A, Mejia-Renteria H, et al
    Angina after percutaneous coronary interventions.
    Eur Heart J. 2025 Oct 17:ehaf771. doi: 10.1093.
    >> Share

  22. GARCIA-PAVIA P, Gonzalez-Lopez E, Anderson LJ, Cappelli F, et al
    Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association.
    Eur Heart J. 2025 Oct 7:ehaf710. doi: 10.1093.
    >> Share

    September 2025
  23. BLEIZIFFER S, Leuschner F, Rudolph TK, Vonthein R, et al
    Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial.
    Eur Heart J. 2025 Sep 3:ehaf519. doi: 10.1093.
    >> Share

    August 2025
  24. KANG DY, Wee SB, Ahn JM, Park H, et al
    Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial.
    Eur Heart J. 2025 Aug 31:ehaf652. doi: 10.1093.
    >> Share

  25. SANDNER S, Gaudino M, Agewall S, Bonalumi G, et al
    Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thor
    Eur Heart J. 2025 Aug 30:ehaf423. doi: 10.1093.
    >> Share

  26. VAN BELLE E, Parma R, Teles RC, Saia F, et al
    Atlas of interventional cardiology 2023: European Society of Cardiology and European Association of Percutaneous Coronary Interventions.
    Eur Heart J. 2025 Aug 29:ehaf698. doi: 10.1093.
    >> Share

  27. MANGIACAPRA F, Paolucci L, De Bruyne B, Rioufol G, et al
    Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis.
    Eur Heart J. 2025 Aug 20:ehaf504. doi: 10.1093.
    >> Share

  28. GUO ZN, Abuduxukuer R, Wang C, Qu Y, et al
    Remote ischaemic conditioning improves outcomes of ischaemic stroke treated by endovascular thrombectomy: the SERIC-EVT trial.
    Eur Heart J. 2025 Aug 12:ehaf570. doi: 10.1093.
    >> Share

  29. CHEN J, Xu C, Qiu L, Li B, et al
    Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial.
    Eur Heart J. 2025 Aug 1:ehaf481. doi: 10.1093.
    >> Share

    July 2025
  30. SCHLAGER O, De Carlo M, Mazzolai L, Bura-Riviere A, et al
    Antithrombotic treatment following revascularization for chronic limb-threatening ischaemia: a scientific statement of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society of Cardiology Wo
    Eur Heart J. 2025;46:2742-2759.
    >> Share

  31. OCCHIPINTI G, Laudani C, Galli M, Ortega-Paz L, et al
    Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis.
    Eur Heart J. 2025 Jul 11:ehaf473. doi: 10.1093.
    >> Share

  32. FEZZI S, Scheller B, Cortese B, Alfonso F, et al
    Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.
    Eur Heart J. 2025;46:2498-2519.
    >> Share

  33. FAZEL R, Rao SV, Cohen DJ, Secemsky EA, et al
    Radial vs femoral access for percutaneous coronary intervention: temporal trends and outcomes in the USA.
    Eur Heart J. 2025 Jul 4:ehaf426. doi: 10.1093.
    >> Share

    June 2025
  34. RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al
    Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.
    Eur Heart J. 2025;46:2052-2062.
    >> Share

  35. MAHENDIRAN T, Bouisset F, Tonino P, Pijls NHJ, et al
    Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis.
    Eur Heart J. 2025;46:2092-2100.
    >> Share

  36. ALI ZA, Shin D, Vijayvergiya R, Gawalkar AA, et al
    Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trial.
    Eur Heart J. 2025 Jun 5:ehaf331. doi: 10.1093.
    >> Share

    May 2025
  37. KIM MC, Park SJ, Park DW, Ahn JM, et al
    Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trial.
    Eur Heart J. 2025 May 29:ehaf273. doi: 10.1093.
    >> Share

  38. MONTANARO C, Arvanitaki A, Kerrigan W, Kadani Z, et al
    The Fontan Adult Brompton clinical score and mortality risk.
    Eur Heart J. 2025;46:1933-1945.
    >> Share

  39. HANSSON EC, Omerovic E, Venetsanos D, Alfredsson J, et al
    Coronary artery bypass grafting with or without preoperative physiological stenosis assessment: a SWEDEHEART study.
    Eur Heart J. 2025 May 16:ehaf327. doi: 10.1093.
    >> Share

  40. POUNCEY AL, Sweeting MJ, Bicknell C, Powell JT, et al
    Sex-specific differences in alive hospital discharge following infrarenal abdominal aortic aneurysm repair.
    Eur Heart J. 2025;46:1705-1716.
    >> Share

  41. FEZZI S, Giacoppo D, Fahrni G, Latib A, et al
    Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
    Eur Heart J. 2025;46:1586-1599.
    >> Share

  42. ZHANG Q, Li H, Zhuang T, Xu L, et al
    CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9 pathway.
    Eur Heart J. 2025;46:1645-1658.
    >> Share

    April 2025
  43. BAY B, Tanner R, Gao M, Oliva A, et al
    Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary interventiondagger.
    Eur Heart J. 2025 Apr 10:ehaf196. doi: 10.1093.
    >> Share

    March 2025
  44. JIA P, Zhao G, Huang Y, Zou Z, et al
    Remote ischaemic pre-conditioning, kidney injury, and outcomes after coronary angiography and intervention: a randomized trial.
    Eur Heart J. 2025 Mar 11:ehaf135. doi: 10.1093.
    >> Share

  45. CALAFIORE AM, Prapas S, Gaudino M
    Arterial conduits for coronary bypass grafting: the set-point concept.
    Eur Heart J. 2025;46:922-925.
    >> Share

    February 2025
  46. THELIN S, Modrau IS, Duvernoy O, Dalen M, et al
    No-touch vein grafts in coronary artery bypass surgery: a registry-based randomized clinical trial.
    Eur Heart J. 2025 Feb 19:ehaf018. doi: 10.1093.
    >> Share

    January 2025
  47. WILKINSON C, Bhatty A, Batra G, Aktaa S, et al
    Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2025;46:190-214.
    >> Share

    December 2024
  48. FERREIRA D, Hardy J, Meere W, Butel-Simoes L, et al
    Fasting vs. no fasting prior to catheterization laboratory procedures: the SCOFF trial.
    Eur Heart J. 2024;45:4990-4998.
    >> Share

    November 2024
  49. OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al
    Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
    Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093.
    >> Share

  50. WANG Y, Zeller M, Auffret V, Georgiopoulos G, et al
    Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score.
    Eur Heart J. 2024;45:4564-4578.
    >> Share

  51. LANDMESSER U, Ali ZA, Maehara A, Matsumura M, et al
    Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
    Eur Heart J. 2024;45:4630-4643.
    >> Share

    October 2024
  52. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
    Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
    Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
    >> Share

  53. KANG D, Choi KH, Kim H, Park H, et al
    Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
    Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
    >> Share

  54. SANDNER S, Antoniades C, Caliskan E, Czerny M, et al
    Intra-operative and post-operative management of conduits for coronary artery bypass grafting: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Surgery and the European Association for Cardio-Thoraci
    Eur Heart J. 2024 Oct 16:ehae654. doi: 10.1093.
    >> Share

    September 2024
  55. LIU W, Cui C, Wang B
    Six-vessel fenestrated physician-modi fi ed stent grafts for treating thoracic aortic dissecting aneurysm and giant abdominal aortic aneurysm.
    Eur Heart J. 2024;45:3765.
    >> Share

  56. LIUZZO G, Patrono C
    Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy after drug-eluting stenting in acute coronary syndromes?
    Eur Heart J. 2024;45:3108-3110.
    >> Share

  57. EITEL I, Saraei R, Jurczyk D, Fach A, et al
    Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial.
    Eur Heart J. 2024 Sep 1:ehae587. doi: 10.1093.
    >> Share

  58. TANIWAKI M, Haner JD, Kakizaki R, Ohno Y, et al
    Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
    Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093.
    >> Share

    August 2024
  59. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
    Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
    Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
    >> Share

  60. VALGIMIGLI M, Landi A
    Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution.
    Eur Heart J. 2024 Aug 28:ehae542. doi: 10.1093.
    >> Share

  61. SCHELLER B, Zeller T
    Paclitaxel-coated balloons: the more you gain the more you get.
    Eur Heart J. 2024;45:2848-2850.
    >> Share

  62. KO YG, Lee SJ, Ahn CM, Lee SH, et al
    Intravascular ultrasound-guided drug-coated balloon angioplasty for femoropopliteal artery disease: a clinical trial.
    Eur Heart J. 2024;45:2839-2847.
    >> Share

  63. RICHTER M, Venkiteswaran VK, de Vries JP, Misra S, et al
    APOLLO: advanced magnetic probes for minimally invasive endovascular interventions.
    Eur Heart J. 2024;45:2589-2591.
    >> Share

  64. PEDICINO D, Vergallo R
    Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
    Eur Heart J. 2024;45:2592-2593.
    >> Share

    July 2024
  65. BESOLA L, Colli A, De Caterina R
    Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
    Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
    >> Share

  66. KANG J, Yun J, Park KW, Park M, et al
    Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
    Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
    >> Share

  67. CREA F
    Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
    Eur Heart J. 2024;45:2463-2467.
    >> Share

  68. AHMAD Y, Lansky AJ
    Periprocedural myocardial infarction: thresholds of (in)significance.
    Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
    >> Share

  69. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
    Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
    Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
    >> Share

  70. ANDREOTTI F, De Caterina R
    Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed.
    Eur Heart J. 2024 Jul 16:ehae402. doi: 10.1093.
    >> Share

  71. GE Y, Zhang H, Guo W
    First in man: blocking the false lumen backflow of aortic dissection after thoracic endovascular aortic repair by an off-the-shelf EndoSeal system.
    Eur Heart J. 2024;45:2461.
    >> Share

  72. GOROG DA
    Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters.
    Eur Heart J. 2024;45:2232-2234.
    >> Share

    June 2024
  73. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
    Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
    Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
    >> Share

  74. HOLFELD J, Nagele F, Polzl L, Engler C, et al
    Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
    Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
    >> Share

  75. SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al
    Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular In
    Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093.
    >> Share

  76. COUGHLAN JJ, Durand R, Byrne RA
    An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
    Eur Heart J. 2024;45:2063-2065.
    >> Share

  77. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
    Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
    Eur Heart J. 2024;45:2052-2062.
    >> Share

  78. BEERKENS FJ, Bhatt DL
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
    Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
    >> Share

    May 2024
  79. REN J, Bowyer A, Tian DH, Royse C, et al
    Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
    Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
    >> Share

  80. VAN DE KAR MRD, van Brakel TJ, Van't Veer M, van Steenbergen GJ, et al
    Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
    Eur Heart J. 2024 May 29:ehae267. doi: 10.1093.
    >> Share

  81. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
    Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
    >> Share

  82. KWON O, Ahn JH, Koh JS, Park Y, et al
    Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
    Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
    >> Share

  83. HARIK L, Gaudino M
    Coronary angiography and bypass surgery: born together and now going separate ways?
    Eur Heart J. 2024;45:1816-1818.
    >> Share

  84. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
    Coronary bypass surgery guided by computed tomography in a low-risk population.
    Eur Heart J. 2024;45:1804-1815.
    >> Share

  85. ROFFI M, Meier B, Gallino A
    Fifty years of percutaneous transluminal angioplasty.
    Eur Heart J. 2024;45:1779-1780.
    >> Share

  86. GRIMALDI S, Migliorini P, Puxeddu I, Rossini R, et al
    Aspirin hypersensitivity: a practical guide for cardiologists.
    Eur Heart J. 2024;45:1716-1726.
    >> Share

  87. LEE YJ, Shin S, Kwon SW, Suh Y, et al
    Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials.
    Eur Heart J. 2024 May 16:ehae249. doi: 10.1093.
    >> Share

  88. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
    Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
    Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
    >> Share

  89. ABOYANS V, De Carlo M
    Caring for patients with lower extremity artery disease: going beyond stents and bypass grafts.
    Eur Heart J. 2024;45:1644-1646.
    >> Share

  90. SHIBA M, Fukutome K, Higuchi Y
    Involvement of cholesterol crystals in the mechanism of aortogenic cerebral infarction: an angioscopic study.
    Eur Heart J. 2024;45:1686.
    >> Share

  91. VERGALLO R, Patrono C
    Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
    Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
    >> Share

    April 2024
  92. KIM YY, Lluri G, Haeffele C, Daugherty T, et al
    Hepatocellular carcinoma in survivors after Fontan operation: a case-control study.
    Eur Heart J. 2024;45:1477-1480.
    >> Share

  93. VERGALLO R, Galiuto L
    Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
    Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
    >> Share

  94. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
    Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
    Eur Heart J. 2024;45:1285.
    >> Share

  95. MATSUMURA H, Yashima F, Shimoji K
    Spontaneous kissing stent for total occlusion of the left main trunk complicated by Stanford Type A aortic dissection.
    Eur Heart J. 2024;45:1179.
    >> Share

    March 2024
  96. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    >> Share

  97. VERGALLO R, Galiuto L
    Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
    Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
    >> Share

    February 2024
  98. IKEDA R, Hiraoka A, Yoshitaka H
    Rupture of a 34-year-old Dacron graft after descending aortic replacement.
    Eur Heart J. 2024;45:636.
    >> Share

  99. XIE Y, Yang P, Hu J
    Off-the-shelf use of a novel unibody single-branched stent for open repair of a double chimney graft-induced retrograde type A aortic dissection.
    Eur Heart J. 2024;45:635.
    >> Share

  100. TARANTINI G, Putorti F, Nai Fovino L
    10-Year optical coherence tomography follow-up of 'full-plastic jacket' with bioresorbable vascular scaffolds.
    Eur Heart J. 2024;45:556.
    >> Share

  101. NISHIHIRA K, Asano Y, Shibata Y
    Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy.
    Eur Heart J. 2024 Feb 15:ehae073. doi: 10.1093.
    >> Share

    January 2024
  102. SENIOR R, Khattar RS
    To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
    Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
    >> Share

  103. NAKAJIMA A, Okutsu M, Nakamura S
    Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy.
    Eur Heart J. 2024;45:315.
    >> Share

  104. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    >> Share

  105. CAPRANZANO P, Moliterno D, Capodanno D
    Aspirin-free antiplatelet strategies after percutaneous coronary interventions.
    Eur Heart J. 2024 Jan 18:ehad876. doi: 10.1093.
    >> Share

  106. HAMILTON DE, Albright J, Seth M, Painter I, et al
    Merging machine learning and patient preference: a novel tool for risk prediction of percutaneous coronary interventions.
    Eur Heart J. 2024 Jan 17:ehad836. doi: 10.1093.
    >> Share

  107. VERGALLO R, Galiuto L
    Shedding the optical coherence tomography light on the treatment of complex coronary bifurcation lesions.
    Eur Heart J. 2024;45:159-160.
    >> Share

  108. COSTA F, Montalto C, Valgimigli M
    One or 3 months dual antiplatelet therapy in high bleeding risk patients: splitting hair or aiming at the bullseye?
    Eur Heart J. 2024;45:71-72.
    >> Share

    December 2023
  109. BRIGNOLE M, Deharo JC
    Different techniques of venous access for CIEDs: advantages and disadvantages.
    Eur Heart J. 2023;44:4859-4861.
    >> Share

  110. ALFONSO F, Marschall A, Rivero F
    Revascularization for left main coronary artery disease.
    Eur Heart J. 2023;44:4893.
    >> Share

  111. PERSSON J, Ivert T, Omerovic E
    Observational studies are needed to complete the body of evidence for left main coronary artery disease revascularization strategies.
    Eur Heart J. 2023;44:4894.
    >> Share

  112. CHARLES P, Ditac G, Montoy M, Thenard T, et al
    Intra-pocket ultrasound-guided axillary vein puncture vs. cephalic vein cutdown for cardiac electronic device implantation: the ACCESS trial.
    Eur Heart J. 2023;44:4847-4858.
    >> Share

  113. LI J, Li Q, Shu C
    Aortic intimal intussusception induced by stent-graft during endovascular repair of acute type B aortic dissection.
    Eur Heart J. 2023;44:4813.
    >> Share

    November 2023
  114. VERGALLO R, Volpe M
    Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?
    Eur Heart J. 2023 Nov 28:ehad792. doi: 10.1093.
    >> Share

  115. ZHAO Y, Chen Y
    What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in high-bleeding risk: 1 month or 3 months?
    Eur Heart J. 2023 Nov 20:ehad728. doi: 10.1093.
    >> Share

  116. PEDICINO D, Liuzzo G
    Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?
    Eur Heart J. 2023 Nov 18:ehad733. doi: 10.1093.
    >> Share

  117. GARCIA-MOLL X
    Where there is smoke there is risk: is there an irreversible threshold?
    Eur Heart J. 2023;44:4473-4475.
    >> Share

  118. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
    >> Share

  119. KIM H, Kang DY, Lee J, Choi Y, et al
    Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
    Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
    >> Share

  120. CREA F
    Hot topics in interventional cardiology: left main disease, heavily calcified coronary stenoses, and physiology-guided percutaneous coronary interventions.
    Eur Heart J. 2023;44:4295-4299.
    >> Share

  121. BYRNE RA, Fremes S, Capodanno D, Czerny M, et al
    2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
    Eur Heart J. 2023;44:4310-4320.
    >> Share

  122. JOHNSON NP, Ahn JM
    Left main PCI: beware the circumflex!
    Eur Heart J. 2023;44:4337-4339.
    >> Share

  123. BARBATO E, Gallinoro E, Abdel-Wahab M, Andreini D, et al
    Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group.
    Eur Heart J. 2023;44:4340-4356.
    >> Share

  124. WANG HY, Zhang R, Dou K, Huang Y, et al
    Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality.
    Eur Heart J. 2023;44:4324-4336.
    >> Share

    October 2023
  125. ALI ZA, Shin D
    Intravascular imaging: a glass half empty or half full?
    Eur Heart J. 2023;44:3856-3858.
    >> Share

    September 2023
  126. KI YJ, Han K, Kim HS, Han JK, et al
    Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study.
    Eur Heart J. 2023 Sep 26:ehad616. doi: 10.1093.
    >> Share

    July 2023
  127. FAZEL R, Yeh RW, Cohen DJ, Rao SV, et al
    Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA.
    Eur Heart J. 2023 Jul 19:ehad430. doi: 10.1093.
    >> Share

    April 2023
  128. COLOMBO A, Leone PP
    Redefining the way to perform percutaneous coronary intervention: a view in search of evidence.
    Eur Heart J. 2023 Apr 11:ehad215. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016